Skip to Main Content

Author Details

Nicola Fusco
IEO European Institute of Oncology IRCCS
2002
167
28
PMIDPaper TitleJournal TitlePublished Year
37072171In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study.J Clin Pathol2024
37770765Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.Virchows Arch2024
36096991Clinical features of type 1 and 2 refractory celiac disease: Results from a large cohort over a decade.Dig Liver Dis2023
37671051Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis.Front Oncol2023
37595344Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey.Crit Rev Oncol Hematol2023
37511789Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods.J Pers Med2023
37640801Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing.Cytopathology2023
37763157Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking.J Pers Med2023
37021548Metaplastic breast cancer: an all-round multidisciplinary consensus.Eur J Cancer Prev2023
36980181Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation.Cells2023
37109309Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies.J Clin Med2023
37077201Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test.Front Mol Biosci2023
37376974Characterization of the immune environment in pregnancy-associated breast cancer.Future Oncol2023
37173958Value of Artificial Intelligence in Evaluating Lymph Node Metastases.Cancers (Basel)2023
37074482Letter to the editor regarding the article "pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients".Breast Cancer Res Treat2023
37372340Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management.Genes (Basel)2023
37038997Computational pathology to improve biomarker testing in breast cancer: how close are we?Eur J Cancer Prev2023
37038998Immune plasticity in pregnancy-associated breast cancer tumorigenesis.Eur J Cancer Prev2023
37437342The immunogram of inflammatory breast cancer.Cancer Treat Rev2023
37302048Technical aspects and validation of custom digital algorithms for hand volumetry.Technol Health Care2023
36477768Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study.Br J Surg2023
36916425The molecular landscape of breast mucoepidermoid carcinoma.Cancer Med2023
36836595Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma.J Pers Med2023
36428107Significant association between FGFR1 mutation frequency and age in central giant cell granuloma.Pathology2023
36833303Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances.Genes (Basel)2023
36831181First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor.Biomedicines2023
36768889Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs).Int J Mol Sci2023
36674436Impact of Physical Rehabilitation on Bone Biomarkers in Non-Metastatic Breast Cancer Women: A Systematic Review and Meta-Analysis.Int J Mol Sci2023
36900178Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution.Cancers (Basel)2023
36758417Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases.Pathol Res Pract2023
36660432Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers.Front Mol Biosci2023
34229592Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology.Anticancer Agents Med Chem2022
35807124Axillary Web Syndrome in Breast Cancer Women: What Is the Optimal Rehabilitation Strategy after Surgery? A Systematic Review.J Clin Med2022
35444029Lights on HBME-1: the elusive biomarker in thyroid cancer pathology.J Clin Pathol2022
35347414Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer.World J Urol2022
35372498HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer.Front Mol Biosci2022
35458148Vitamin D Deficiency in Women with Breast Cancer: A Correlation with Osteoporosis? A Machine Learning Approach with Multiple Factor Analysis.Nutrients2022
35629172FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint.J Pers Med2022
35414722Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC).Pathologica2022
35745217Gluten Induces Subtle Histological Changes in Duodenal Mucosa of Patients with Non-Coeliac Gluten Sensitivity: A Multicentre Study.Nutrients2022
37303941Biobanking in the digital pathology era.Oncol Res2022
36579554Effects of Ultrasound-Guided Injection Combined with a Targeted Therapeutic Exercise in Breast Cancer Women with Subacromial Pain Syndrome: A Randomized Clinical Study.J Pers Med2022
36428975Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for <i>PIK3CA</i> Testing in HR+/HER2- Breast Cancer.Cells2022
36798789A Software Suite for Limb Volume Analysis Applicable in Clinical Settings: Upper Limb Quantification.Front Bioeng Biotechnol2022
36533819Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management.J Vis Exp2022
36627898Improving HER2 testing reproducibility in HER2-low breast cancer.Cancer Drug Resist2022
36627895Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.Cancer Drug Resist2022
36143438HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes.Life (Basel)2022
35934262The evolving landscape of anatomic pathology.Crit Rev Oncol Hematol2022
36358845An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma.Cancers (Basel)2022
  • 1 - 50 of 167

Recommended Authors

Kevin Punie
Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 3
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 8
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 7
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Samuel Leung
University of British Columbia
Career Start Year 2007
Number of shared co-authors 2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 1
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 5
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 6
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 3
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Peter A Fasching
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 3
Fatima Cardoso
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 6
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Peter Bult
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 6
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 9
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 7
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 6
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 0
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 6
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 7
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 0
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 5
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 6

Collaborators

Carmen Criscitiello
University of Milano
Co-authored papers 17
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 12
Giuseppe Curigliano
University of Milan
Co-authored papers 12
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Salvatore Piscuoglio
University of Basel
Co-authored papers 10
Chiara Corti
University of Milano
Co-authored papers 10
Charlotte K Y Ng
University of Bern
Co-authored papers 9
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 9
Luciano G Martelotto
Monash University
Co-authored papers 8
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Co-authored papers 8
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 5
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Rita A Sakr
Universite Libre de Bruxelles
Co-authored papers 3
Alena Sk??lov??
Charles University
Co-authored papers 2
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Ilan Weinreb
University Health Network
Co-authored papers 2
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 2
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Lester D R Thompson
Woodland Hills Medical Center
Co-authored papers 1
Christine How
Ontario Cancer Institute, University Health Network (UHN)
Co-authored papers 1
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 1
Kenneth C Chu
Ontario Institute for Cancer Research
Co-authored papers 1
Laura Mullen
Ontario Institute for Cancer Research
Co-authored papers 1
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 1
Javier A Alfaro
International Centre for Cancer Vaccine Science, University of Gdansk
Co-authored papers 1
Nicholas Buchner
Ontario Institute for Cancer Research
Co-authored papers 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Release 1.2